Anti-SARS-CoV-2S Antibody Levels in Healthcare Workers 10 Months after the Administration of Two BNT162b2 Vaccine Doses in View of Demographic Characteristic and Previous COVID-19 Infection

Antibody levels that confer full protection against SARS-CoV-2 infection after the administration of different vaccine brands as well as the factors influencing the humoral immune response have been analyzed extensively ever since the vaccination program was launched in late 2020. The aim of this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolszczak-Biedrzycka, Blanka, Bieńkowska, Anna, Zaborowska, Joanna Ewa, Smolińska-Fijołek, Elwira, Biedrzycki, Grzegorz, Dorf, Justyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146273/
https://www.ncbi.nlm.nih.gov/pubmed/35632498
http://dx.doi.org/10.3390/vaccines10050741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146273/
https://www.ncbi.nlm.nih.gov/pubmed/35632498
http://dx.doi.org/10.3390/vaccines10050741

Ejemplares similares